MAREVAN™ Tablets - Medsafe
MAREVAN™ Tablets 1 MAREVAN™ Tablets Warfarin Tablets 1 mg, 3 mg and 5 mg New Zealand Consumer Medicine Information . What is in this leaflet
Download MAREVAN™ Tablets - Medsafe
Information
Domain:
Source:
Link to this page:
Documents from same domain
ADVANTAN Presentation Uses - Medsafe
www.medsafe.govt.nzADVANTAN® Data Sheet Page 1 of 9 ADVANTAN® Methylprednisolone aceponate 0.1% ointment/cream . Presentation 1 g cream or ointment contains 1 mg (0.1%) methylprednisolone aceponate.
LOXALATE 1. Product Name - Medsafe Home Page
www.medsafe.govt.nzPage 5of 21 at risk, such as the elderly, or patients with cirrhosis, or if used in combination with other medications which may cause hyponatraemia.
DATA SHEET 1 CLEXANE AND CLEXANE FORTE ... - …
www.medsafe.govt.nzNew Zealand Data Sheet June 2017 . clexane-clexane-forte-ccdsv13-dsv18-16jun17 Page 2 . 100 mg injection enoxaparin sodium 100mg (equivalent to …
SEPTANEST Articaine hydrochloride 4% with …
www.medsafe.govt.nzSEPTANEST Articaine hydrochloride 4% with adrenaline 1:100,000 Injection for local and regional dental anaesthesia DESCRIPTION SEPTANEST is a sterile aqueous solution that contains articaine hydrochloride 4% (40 mg/mL) with adrenaline acid tartrate in a 1:100,000 strength.
BOOSTRIX - Medsafe Home Page
www.medsafe.govt.nz1 BOOSTRIX®. Combined diphtheria, tetanus, acellular pertussis (dTpa) vaccine . CONSUMER MEDICINE INFORMATION WHAT IS IN THIS LEAFLET? This leaflet answers some of the common questions about BOOSTRIX vaccine.
NEW ZEALAND DATA SHEET - Medsafe
www.medsafe.govt.nzNEW ZEALAND DATA SHEET Cymevene ® DS 170831 2 of 26 Caution: Cymevene must only be administered by IV infusion over 1 hour, preferably via a
Edition Draft - Medsafe
www.medsafe.govt.nzPart 4, Ed Draft Page 2 of 9 Section 1: Good Manufacturing Practice Documentation 1.1. When is GMP Documentation Required? Medsafe requires evidence of Good Manufacturing Practice (GMP) compliance for
Data Sheet 1 PRODUCT NAME 2 QUALITATIVE AND …
www.medsafe.govt.nzNew Zealand Data Sheet 31 July 2017 Lantus – insulin glargine lantus-ccdsv19-dsv11-31jul17 Page 1 Data Sheet 1 PRODUCT NAME Lantus 100 IU/mL solution for injection in 10 …
NEW ZEALAND DATA SHEET MESTINON® - Medsafe
www.medsafe.govt.nzNEW ZEALAND DATA SHEET MESTINON® MESTINON Page 4 of 8 As the severity of myasthenia gravis often fluctuates considerably, particular care is required to
DATA SHEET PREDNISONE - Medsafe
www.medsafe.govt.nz• Epilepsy and/or seizure disorder • Peptic ulceration • Previous steroid myopathy • Tuberculosis • Patients with myasthenia gravis receiving anticholinesterase therapy since
Related documents
Dissolution Testing of Orally Disintegrating Tablets
www.dissolutiontech.com6 Dissolution Technologies | MAY 2003 IntroductionO rally disintegrating tablets contain a wide variety of pharmaceutical actives covering many therapeutic categories,and can be
Variation Assessment Report Relifex 1 g Film …
www.mhra.gov.ukMHRA PAR-Relifex 1g Film-coated Tablets 3 RELIFEX 1 G FILM-COATED TABLETS PL 15142/0105 SCIENTIFIC DISCUSSION TABLE OF CONTENTS Introduction Page 4
BENDROFLUMETHIAZIDE 2.5MG TABLETS PL …
www.mhra.gov.ukUKPAR Bendroflumethiazide 2.5 and 5 mg Tablets PL 17907/0082-3 6 Other ingredients consist of pharmaceutical excipients, namely lactose anhydrous,
REVISION OF MONOGRAPH ON TABLETS - World …
www.who.intDocument QAS/09.324/Final March 2011 REVISION OF MONOGRAPH ON TABLETS Final text for addition to The International Pharmacopoeia This monograph was adopted by the Forty-fourth WHO Expert Committee on
PACKAGE LEAFLET: INFORMATION FOR THE USER …
www.medicines.org.ukPACKAGE LEAFLET: INFORMATION FOR THE USER . Vermox® 100 mg tablets. Mebendazole . Vermox is a registered trademark . Read all of this leaflet carefully before you start using this medicine.
SCX-4300 - samsung.com
www.samsung.comSCX-4300 Mono Laser Multifunction Printer ©2008 Samsung Electronics America, Inc. Samsung is a registered mark of Samsung Electronics Corp., Ltd.